UBS ASSET MANAGEMENT AMERICAS LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$933,543
-14.0%
171,292
+39.4%
0.00%
-100.0%
Q2 2023$1,085,3560.0%122,9170.0%0.00%0.0%
Q1 2023$1,085,356
+26.6%
122,917
+9.6%
0.00%
Q4 2022$857,100
-99.9%
112,186
+2.2%
0.00%
Q3 2022$781,271,000
-9.2%
109,729
+3.1%
0.00%
Q2 2022$860,776,000
-63.9%
106,400
-38.0%
0.00%
-100.0%
Q1 2022$2,382,405,000
-45.3%
171,643
+10.5%
0.00%
-50.0%
Q4 2021$4,359,346,000
-15.0%
155,358
+3.0%
0.00%0.0%
Q3 2021$5,125,692,000
-15.5%
150,800
+1.6%
0.00%
-33.3%
Q2 2021$6,063,870,000
-46.0%
148,406
-46.8%
0.00%
-40.0%
Q1 2021$11,237,414,000
-31.6%
279,121
+0.5%
0.01%
-37.5%
Q4 2020$16,423,771,000
+37.6%
277,757
+13.1%
0.01%
+33.3%
Q3 2020$11,938,227,000
+5.1%
245,491
+4.6%
0.01%
-14.3%
Q2 2020$11,355,367,000
+539.2%
234,712
+267.0%
0.01%
+600.0%
Q1 2020$1,776,420,000
+16.4%
63,946
+25.3%
0.00%0.0%
Q4 2019$1,526,608,000
-3.7%
51,023
-0.5%
0.00%0.0%
Q3 2019$1,585,262,000
-34.4%
51,303
+2.6%
0.00%
-50.0%
Q2 2019$2,415,000,00050,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders